Virtus LifeSci Biotech Clinical Trials ETF (Virtus Biotech Clinical Trials ) ETF
BBC
Forsinket 0 min$43.36+1.47 (+3.51%)
Indlæser graf...
Virtus Biotech Clinical Trials
Åben42.78
Høj43.38
Lav42.67
Omsætning7.79k
P/EN/A
BørsværdiN/A
52-ugers høj48.18
52-ugers lav18.77
Gns. omsætning22.62k
UdbytteN/A
BetaN/A
EPSN/A
Om Virtus LifeSci Biotech Clinical Trials ETF (Virtus Biotech Clinical Trials ) ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.